Absence of central effects with levocabastine eye drops
- 30 September 1990
- Vol. 45 (7) , 552-554
- https://doi.org/10.1111/j.1398-9995.1990.tb00531.x
Abstract
Twelve healthy volunteers were randomly allocated to receiving in a double-blind cross-over fashion levocabastin eye drops (0.5 mg/ml solution) and placebo. They were advised to instill 2 drops per eye, four times daily. Each treatment was administered for a period of 1 week. Before and after each treatment period psychomotor function was assessed using Critical Flicker Fusion Test and the Choice Reaction Time Test. At the same time intervals a subjective evaluation of sedation was given using a Visual Analogue of Sedation. Both objective and subjective measurements showed that no significant treatment effects could be detected. It is concluded that repeat insillations of levocabastine eye drops are devoid of any sedative side effects.Keywords
This publication has 8 references indexed in Scilit:
- Effect of topical levocabastine on allergic and non‐allergic perennial rhinitisAllergy, 1988
- Topical levocabastine, a selective H1 antagonist, in seasonal allergic rhinoconjunctivitisAllergy, 1987
- Oral antiallergic activity in ascaris hypersensitive dogs: A study of known antihistamines and of the new compounds ramastine (R 57 959) and levocabastine (R 50 547)Drug Development Research, 1986
- Levocabastine (R 50547): The prototype of a chemical series of compounds with specific H1‐antihistaminic activityDrug Development Research, 1986
- A Double‐Blind Evaluation of Topical Levocabastine, a New Specific H1 Antagonist in Patients with Allergic ConjunctivitisAllergy, 1985
- Critical Flicker Fusion Frequency (CFF): The Effects of Psychotropic CompoundsPharmacopsychiatry, 1982
- MEASUREMENT OF PAINPublished by Elsevier ,1974
- 328. Note: The Use of None-Parametric Methods in the Statistical Analysis of the Two-Period Change-Over DesignPublished by JSTOR ,1972